Bleeding rates with severe hemophilia A fall with prophylaxis: Study
Prophylactic, or preventive, treatment with factor VIII (FVIII) replacement therapy for four years reduced annual bleeding rates by 91% for...
hemophilia
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy
1 Introduction Hemophilia is an X-linked recessive disorder caused by the deficiency in coagulation factor VIII (FVIII; hemophilia A) or...
UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia B
Anette von Drygalski, MD, PharmD, is the director of the Center for Bleeding and Clotting Disorders at UC San Diego...
Cost of care higher for older, sicker hemophilia A patients: Study
Brazilian hemophilia A patients who are 19 or older had significantly higher median care costs per patient per year than...
Hemophilia Treatment Market Set to Reach USD 18.7 Billion
NEWARK, Del, June 25, 2024 (GLOBE NEWSWIRE) -- The hemophilia treatment market is forecast to reach USD 12.1 billion in...
Patients With Plasminogen Deficiency Should Receive Care at Hemophilia Treatment Centers: Dr Amy Shapiro
Part 2 of this interview featured a discussion with Amy Shapiro, MD, medical director, Indiana Hemophilia and Thrombosis Center, on...
